当前位置: X-MOL 学术Alzheimers Dement. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study
Alzheimer's & Dementia ( IF 13.0 ) Pub Date : 2021-11-02 , DOI: 10.1002/alz.12477
Mercè Boada 1, 2 , Oscar L López 3 , Javier Olazarán 4, 5 , Laura Núñez 6 , Michael Pfeffer 7 , Orlando Puente 8 , Gerard Piñol-Ripoll 9 , José E Gámez 10 , Fernando Anaya 11 , Dobri Kiprov 12 , Montserrat Alegret 1 , Carlota Grifols 6 , Miquel Barceló 6 , Jordi Bozzo 6 , Zbigniew M Szczepiorkowski 13, 14 , Antonio Páez 6 ,
Affiliation  

We report the effects of plasma exchange (PE) with albumin replacement on neuropsychological, neuropsychiatric, and quality-of-life (QoL) outcomes in mild-to-moderate Alzheimer's disease (AD) patients in a phase 2b/3 trial (Alzheimer's Management by Albumin Replacement [AMBAR] study).

中文翻译:

随机 AMBAR 研究中接受白蛋白替代血浆置换治疗的阿尔茨海默病患者的神经心理学、神经精神学和生活质量评估

我们在一项 2b/3 期试验中报告了血浆置换 (PE) 联合白蛋白替代对轻至中度阿尔茨海默病 (AD) 患者的神经心理、神经精神和生活质量 (QoL) 结局的影响(阿尔茨海默病管理)通过白蛋白替代 [AMBAR] 研究)。
更新日期:2021-11-02
down
wechat
bug